Doxorubicin-SMCC
Doxorubicin-SMCC is a agent-linker conjugate for ADC. Doxorubicin-SMCC contains a non-cleavable ADC linker and a DNA topoisomerase II inhibitor Doxorubicin[1].
Product Specifications
CAS Number
[400647-59-8]
Product Name Alternative
Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/doxorubicin-smcc.html
Purity
98.80
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
C[C@@H]1O[C@H](C[C@@H]([C@@H]1O)NC(C2CCC(CC2)CN3C(C=CC3=O)=O)=O)O[C@H]4C[C@](O)(C(CO)=O)CC5=C(O)C(C(C6=C7C(OC)=CC=C6)=O)=C(C7=O)C(O)=C45
Molecular Formula
C39H42N2O14
Molecular Weight
762.76
References & Citations
[1]Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16 (5) :315-337.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
Daunorubicins/Doxorubicins
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PPIAP CRISPRa sgRNA lentivector (set of three targets)(Human)
